| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 21, 2013 | S&P Capital IQ Quantitative Report | N/A | Peregrine Pharmaceuticals | 6 | $69 | | May 20, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | PEREGRINE PHARMACEUTICALS INC (PPHM) 12-months forecast | 1 | $15 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: PEREGRINE PHARM -- PPHM | 1 | $11.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ATHX , CLDX , CRIS , INO , PPHM -- DRUGS | 3 | $34.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for PPHM | 11 | $126.50 | | May 15, 2013 | Zacks Investment Research Inc. | N/A | PEREGRINE PHARM (PPHM) Zacks Company Snapshot | 1 | $11.50 | | May 13, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Peregrine Pharmaceuticals, Inc. | 40 | $460 | | May 13, 2013 | Zacks Investment Research Inc. | N/A | PEREGRINE PHARM (PPHM) Zacks Company Snapshot | 1 | $11.50 | | May 11, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: PEREGRINE PHARMACEUTICLS INC | 5 | $10 |
|
View All Reports for PPHM ... |
|
|
0.17(9.29%) May 21, 4:00PM EDT|After Hours
:
1.71